Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
about
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association studyOrigins, genetic landscape, and emerging therapies of small cell lung cancerWnt signaling pathway in non-small cell lung cancerPharmacogenomics of cisplatin sensitivity in non-small cell lung cancerThe impact of the Cancer Genome Atlas on lung cancer.Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder CancerValproic acid improves second-line regimen of small cell lung carcinoma in preclinical modelsSingle nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancerDisruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatmentSynergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell linesInvestigation of the epidermal growth factor receptor mutation rate in non-small cell lung cancer patients and the analysis of associated risk factors using logistic regression.Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerCopper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.KPT-330 has antitumour activity against non-small cell lung cancer.Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis.Extensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene groupRedesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.Fool's gold, lost treasures, and the randomized clinical trial.A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer.Inhibition of Raf-MEK-ERK and hypoxia pathways by Phyllanthus prevents metastasis in human lung (A549) cancer cell lineThe prognostic role of the class III β-tubulin in non-small cell lung cancer (NSCLC) patients receiving the taxane/vinorebine-based chemotherapy: a meta-analysis.Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation.Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian CancercDNA microarray analysis of the effect of cantharidin on DNA damage, cell cycle and apoptosis-associated gene expression in NCI-H460 human lung cancer cells in vitroModeling the transcriptional consequences of epidermal growth factor receptor ablation in Ras-initiated squamous cancer.Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerThe regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancerOver-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.Anti-ABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway.Ganoderma tsugae Induces S Phase Arrest and Apoptosis in Doxorubicin-Resistant Lung Adenocarcinoma H23/0.3 Cells via Modulation of the PI3K/Akt Signaling Pathwayp53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.Tissue platinum concentration and tumor response in non-small-cell lung cancerDisturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.In vivo selection of autologous MGMT gene-modified cells following reduced-intensity conditioning with BCNU and temozolomide in the dog modelThe significance of epigenetic alterations in lung carcinogenesis.Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy.Ubiquitin-specific protease 4 controls metastatic potential through β-catenin stabilization in brain metastatic lung adenocarcinomaPersonalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.
P2860
Q21261276-2CCA9190-85C1-4F55-8937-B7A250DD085CQ26798218-166C7954-6F8A-4608-96D2-0E3E087207DDQ26825936-F12BE2D3-3E6F-4933-9271-D1291FAD1550Q26863490-66012678-20DC-4242-A814-6D0C7FB6BF02Q28084190-45CCDC35-ADAE-4EE2-AEC9-97A85189CD21Q28552143-5414BE4D-4D9E-423E-9B45-ABBC76D062DCQ28596812-8B863A36-AB3C-486F-92F3-574C90C9ED30Q28816916-DFBA92FC-4CDA-41E2-BC8B-BC2F8CB85410Q33689527-87A72486-F7BB-436C-96E3-32A3409A17D3Q33750712-16F92F58-597F-4E37-B5BD-5A11B6F2ED44Q33844140-750AD81A-0ECC-421D-94A3-0F317FC77140Q33856008-F72BC758-12DF-4328-8A49-FC2C6174901FQ33875938-551904A9-14B5-4F37-A83A-437EDBA78BE8Q33918079-1FCBA10E-4F03-4D66-9375-CE22EBBC23AAQ34000067-2D8CF0F0-BFA2-4BBC-B850-8E3821E1F71CQ34252309-9A4AC3D8-0E09-4B9D-8E3A-4E6FDC165786Q34316489-A15A379C-9793-4610-9441-AC9AA8E5371FQ34572581-757831C9-BBC1-4EEA-A6A4-4ABFAD79C492Q34669260-F3CFE3B3-28C5-4CCD-BC4D-76C3C818B43EQ34768677-0A069951-29AE-4A04-B081-69D805D70729Q35020574-6CED157E-82E7-4C65-80A0-A665ECA82002Q35140489-899950DB-A826-4F23-AADB-4E66B65F011BQ35232780-54A3BFA0-323F-49A6-A7B6-779A1F3C1761Q35374920-6F30A06D-319A-4CFA-93A0-11473AB6E2E6Q35628537-D6232D2F-FADF-4BDF-9857-2ABBB3FB3E6CQ35653271-494513C8-B4B6-4ABB-B1C5-D73139F7CF7BQ35744111-F4312B22-B926-4CB5-8279-DE1DA3200100Q35813690-6431D6F3-A0BF-4662-BDDE-BDE9017378B9Q35854064-28CE22EA-447B-4577-9A0E-060DE858E0A9Q36050053-3CC1F6FA-5D2C-417C-8DF4-7246ACBB40BEQ36076073-F4215530-25C1-47FB-BD45-300079133CBEQ36085351-0238A250-EF23-4DE0-8E41-F896D3AFCCF3Q36222930-05D4EECF-61F7-4AC9-ACEF-CC85A95C52A4Q36290193-4638FB9E-18BB-42AD-8967-AFB384C56C51Q36293500-D404AE87-CBA5-4142-8BA5-BAC69E402169Q36303065-B2B63521-6667-416C-969D-64E443B3AE15Q36457427-35A58D06-474F-43BF-BEAA-9BA9282F9F2DQ36503102-DC58F04A-254F-4863-91D7-C660AF83F278Q36587552-DB1B0406-AAF7-4F0C-BE59-B78D9B044483Q36817080-2677FDB0-46B9-4BA1-B644-1F3C09BD12E8
P2860
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Tumor and host factors that ma ...... ell and small cell lung cancer
@ast
Tumor and host factors that ma ...... ell and small cell lung cancer
@en
Tumor and host factors that ma ...... ell and small cell lung cancer
@nl
type
label
Tumor and host factors that ma ...... ell and small cell lung cancer
@ast
Tumor and host factors that ma ...... ell and small cell lung cancer
@en
Tumor and host factors that ma ...... ell and small cell lung cancer
@nl
prefLabel
Tumor and host factors that ma ...... ell and small cell lung cancer
@ast
Tumor and host factors that ma ...... ell and small cell lung cancer
@en
Tumor and host factors that ma ...... ell and small cell lung cancer
@nl
P2860
P3181
P1476
Tumor and host factors that ma ...... ell and small cell lung cancer
@en
P2093
David J Stewart
P2860
P304
P3181
P356
10.1016/J.CRITREVONC.2009.11.006
P407
P577
2010-09-01T00:00:00Z